Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1938 1
1945 1
1946 1
1947 6
1948 1
1949 2
1950 5
1951 5
1952 4
1953 1
1954 3
1955 5
1956 2
1957 4
1958 3
1959 1
1960 2
1961 2
1962 1
1965 2
1966 2
1967 2
1968 3
1969 1
1970 4
1971 4
1972 4
1973 2
1974 3
1975 3
1976 1
1979 1
1980 1
1981 1
1982 2
1983 3
1985 3
1986 7
1987 8
1988 8
1989 7
1990 7
1991 7
1992 7
1993 5
1994 13
1995 7
1996 7
1997 16
1998 9
1999 10
2000 15
2001 10
2002 12
2003 20
2004 19
2005 21
2006 24
2007 19
2008 27
2009 29
2010 28
2011 33
2012 29
2013 24
2014 33
2015 32
2016 34
2017 46
2018 47
2019 52
2020 62
2021 77
2022 84
2023 62
2024 23

Text availability

Article attribute

Article type

Publication date

Search Results

961 results

Results by year

Filters applied: . Clear all
Page 1
Haemolytic uraemic syndrome.
Michael M, Bagga A, Sartain SE, Smith RJH. Michael M, et al. Lancet. 2022 Nov 12;400(10364):1722-1740. doi: 10.1016/S0140-6736(22)01202-8. Epub 2022 Oct 19. Lancet. 2022. PMID: 36272423 Review.
Cancer Pain and Opioid Use Disorder.
Ganguly A, Michael M, Goschin S, Harris K, McFarland DC. Ganguly A, et al. Among authors: michael m. Oncology (Williston Park). 2022 Sep 7;36(9):535-541. doi: 10.46883/2022.25920973. Oncology (Williston Park). 2022. PMID: 36107782 Free article. Review.
Lumasiran for Advanced Primary Hyperoxaluria Type 1: Phase 3 ILLUMINATE-C Trial.
Michael M, Groothoff JW, Shasha-Lavsky H, Lieske JC, Frishberg Y, Simkova E, Sellier-Leclerc AL, Devresse A, Guebre-Egziabher F, Bakkaloglu SA, Mourani C, Saqan R, Singer R, Willey R, Habtemariam B, Gansner JM, Bhan I, McGregor T, Magen D. Michael M, et al. Am J Kidney Dis. 2023 Feb;81(2):145-155.e1. doi: 10.1053/j.ajkd.2022.05.012. Epub 2022 Jul 14. Am J Kidney Dis. 2023. PMID: 35843439 Free article. Clinical Trial.
Peripherin is a biomarker of axonal damage in peripheral nervous system disease.
Keddie S, Smyth D, Keh RYS, Chou MKL, Grant D, Surana S, Heslegrave A, Zetterberg H, Wieske L, Michael M, Eftimov F, Bellanti R, Rinaldi S, Hart MS, Petzold A, Lunn MP. Keddie S, et al. Among authors: michael m. Brain. 2023 Nov 2;146(11):4562-4573. doi: 10.1093/brain/awad234. Brain. 2023. PMID: 37435933 Free PMC article.
Commonwealth Neuroendocrine Tumour Research Collaboration and the North American Neuroendocrine Tumor Society Guidelines for the Diagnosis and Management of Patients With Lung Neuroendocrine Tumors: An International Collaborative Endorsement and Update of the 2015 European Neuroendocrine Tumor Society Expert Consensus Guidelines.
Singh S, Bergsland EK, Card CM, Hope TA, Kunz PL, Laidley DT, Lawrence B, Leyden S, Metz DC, Michael M, Modahl LE, Myrehaug S, Padda SK, Pommier RF, Ramirez RA, Soulen M, Strosberg J, Sung A, Thawer A, Wei B, Xu B, Segelov E. Singh S, et al. Among authors: michael m. J Thorac Oncol. 2020 Oct;15(10):1577-1598. doi: 10.1016/j.jtho.2020.06.021. Epub 2020 Jul 11. J Thorac Oncol. 2020. PMID: 32663527 Free article. Review.
Precision Oncology in Gastrointestinal Stromal Tumors.
Mechahougui H, Michael M, Friedlaender A. Mechahougui H, et al. Among authors: michael m. Curr Oncol. 2023 Apr 30;30(5):4648-4662. doi: 10.3390/curroncol30050351. Curr Oncol. 2023. PMID: 37232809 Free PMC article. Review.
A neutrophil-centric view of chemotaxis.
Michael M, Vermeren S. Michael M, et al. Essays Biochem. 2019 Oct 31;63(5):607-618. doi: 10.1042/EBC20190011. Essays Biochem. 2019. PMID: 31420450 Review.
961 results